Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study.

Mark RosenthalPaul M ClementMario CamponeMiguel J Gil-GilJohn DeGrootOlivier ChinotAhmed IdbaihHui GanJeffrey RaizerPatrick Yung WenEstela PinedaValerie DonnetDavid MillsMona El-HashimyWarren Mason

Published in: ESMO open (2021)

NCT01934361.

Keyphrases

open label
clinical trial
study protocol
phase ii study
phase iii
double blind
phase ii
randomized controlled trial
placebo controlled
squamous cell carcinoma
radiation therapy
cross sectional
rectal cancer